Publication Name	World Journal of Cardiology
Manuscript ID	100742
Country	Saudi Arabia

Received	2024-08-24 21:35
Peer-Review Started	2024-08-24 21:35
To Make the First Decision
Return for Revision	2024-09-30 10:49
Revised	2024-10-14 11:28
Second Decision	2024-10-23 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-23 12:55
Articles in Press	2024-10-23 12:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-28 06:01
Publish the Manuscript Online	2024-10-31 08:01

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Letter to the Editor
Article Title	Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure
Manuscript Source	Invited Manuscript
All Author List	Mohamed H Laimoud and Ismail R Raslan
ORCID	Author(s) ORCID Number Mohamed H Laimoud http://orcid.org/0000-0002-5069-2813 Ismail R Raslan http://orcid.org/0009-0001-8305-0817
Funding Agency and Grant Number
Corresponding Author	Mohamed H Laimoud, MD, PhD, Associate Professor, Department of Cardiovascular Critical Care, Prince Sultan Cardiac Center, Makkah Al Mukarramah Br Road, As Sulimaniyah, Riyadh, Riyadh 12611, Saudi Arabia. m.laimoud@cu.edu.eg
Key Words	Heart failure; Cardiovascular risk; Diabetes mellitus; Mortality; Sodium-dependent glucose transporter 2 inhibitors
Core Tip	Grubić Rotkvić et al published an observational study on the use of sodium-dependent glucose transporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes mellitus and asymptomatic heart failure. Their findings included reduced cardiac load and improved cardiovascular performance related to the use of SGLT2i. This suggests that SGLT2i are not merely glucose-lowering drugs; they are integral to the broader cardiovascular management in patients with type 2 diabetes mellitus.
Publish Date	2024-10-31 08:01
Citation	<p>Laimoud MH, Raslan IR. Effects of sodium-dependent glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus and asymptomatic heart failure. <i>World J Cardiol</i> 2024; 16(11): 665-668</p>
URL	https://www.wjgnet.com/1949-8462/full/v16/i11/665.htm
DOI	https://dx.doi.org/10.4330/wjc.v16.i11.665

Full Article (PDF)	WJC-16-665-with-cover.pdf
Manuscript File	100742_Auto_Edited_060238.docx
Answering Reviewers	100742-answering-reviewers.pdf
Audio Core Tip	100742-audio.mp3
Conflict-of-Interest Disclosure Form	100742-conflict-of-interest-statement.pdf
Copyright License Agreement	100742-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100742-non-native-speakers.pdf
Peer-review Report	100742-peer-reviews.pdf
Scientific Misconduct Check	100742-scientific-misconduct-check.png
Scientific Editor Work List	100742-scientific-editor-work-list.pdf
CrossCheck Report	100742-crosscheck-report.pdf
CrossCheck Report	100742-crosscheck-report.png